397. Validating the Nosocomial XDR Score: Novel Intervention of Improving Prescription Practices in the Era of Extensively Drug Resistant Pathogens in Hospitals
Session: Poster Abstract Session: HAI: MDRO-GNR/Emerging Resistant Bacterial Pathogens
Thursday, October 5, 2017
Room: Poster Hall CD
Posters
  • ID-week 2017 poster - Validating Nosocomial XDR Score Matar 09-08-2017 2 dm.pdf (288.3 kB)
  • Background: In nosocomial sepsis, it is sometimes difficult to discriminate multi drug resistant (MDR) infections (where empiric regimens usually suffice) from extensively drug resistant (XDR) infections (where first line empiric regimens commonly do not suffice). Delay in initiation of appropriate antimicrobial therapy (DAAT) is independently associated with worse outcomes among patients with XDR vs. MDR infections. A score that predicts XDR nosocomial infection could lead to reduced DAAT, improve outcomes, and contribute to antimicrobial stewardship efforts. In previous analyses, two scores (the "Vitkon score" and the "Michaeli score") were developed to differentiate MDR from XDR nosocomial sepsis. The study aim was to validate these scores on a general hospitalized population with nosocomial sepsis.

    Methods: A retrospective chart review based case-control analysis was conducted on adult patients hospitalized at Assaf Harofeh Medical Center (Israel), from which blood cultures were obtained due to suspected nosocomial sepsis, between 01/01/13 – 28/02/13. All patients were included regardless of their culture results. Validation of the XDR nosocomial sepsis scores were executed by using conventional methodologies and ROC curve analyses.

    Results: Overall, 406 patients with nosocomial sepsis were enrolled: 34 patients had XDR confirmed nosocomial sepsis (cases) and 372 had non-XDR nosocomial sepsis (controls). The "Vitkon score" had a sensitivity of 26%, and the ROC AUC of the "Michaeli score" was 0.55. In univariable analysis, patients with XDR sepsis had increased severity of acute illness indices (p<0.001), suffered from substantial DAAT (p=0.02), and had significant worse clinical outcomes, with longer hospital stays (p=0.005) and higher mortality (p<0.001).

    Conclusion: The study aim was to validate previously developed scores that differentiate MDR from XDR infection, on a cohort of patients with nosocomial sepsis. Yet, as reflected by this study, both scores' performances were inadequate. Larger prospective multicenter studies are needed, in order to develop and later-on validate such a score, which could improve the outcomes of patients with nosocomial XDR infections and contribute to stewardship efforts.

    Matar Yekutiel, MD1, Tsilia Lazarovitch, PhD2, Ronit Zaidenstein, M.D.3, Mor Dadon, BsC4, Chen Daniel, BS1 and Dror Marchaim, MD5, (1)Assaf Harofeh Medical Center, Zerifin, Israel, (2)Unit of Infection Control, Assaf Harofeh Medical Center, Zerifin, Israel, (3)Medicine a, Assaf Harofeh Medical Center, Beer Yaacov, Israel, (4)Assaf Harofeh Medical Center, Beer Yaacov, Israel, (5)Infectious Diseases, Assaf Harofeh Medical Center, Zerifin, Israel

    Disclosures:

    M. Yekutiel, None

    T. Lazarovitch, None

    R. Zaidenstein, None

    M. Dadon, None

    C. Daniel, None

    D. Marchaim, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.